Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Lower Limb Prosthetics Research Standards Working Group Committee, Work group, Advisory group, or Task Force CMS, FDA NICHD This working group helps to determine research standards for lower limb prosthetics.
Lupus Federal Working Group Committee, Work group, Advisory group, or Task Force AHRQ, CDC, FDA, HRSA, OS NIAMS, NCCIH, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH The Lupus Federal Working Group, established on behalf of the Department of Health and Human Services (HHS) Secretary by the National Institutes of Health (NIH), facilitates collaboration among NIH components, other Federal agencies, voluntary and professional organizations, and industry groups with an interest in lupus.
Lyme and Tick-borne Diseases Work Group Committee, Work group, Advisory group, or Task Force CDC, FDA, OS NIAID This workgroup involves members from agencies including the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and the NIH with the purpose of continued coordination and communication of activities, policy updates, events, agency highlights, and other shared interests relating to Lyme disease and other tick-borne diseases.
Mapping of the Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT) and International Classification of Disease (ICD) Clinical Terminology Resource Development CDC, OS NLM The US Department of Health and Human Services (HHS) has set a goal for the nationwide implementation of an interoperable health information technology infrastructure to improve the quality and efficiency of healthcare. Achieving this goal will require that key clinical data elements are captured or recorded in detailed, standardized form (using standard vocabularies, codes, and formats) as close to their original sources (patients, healthcare providers, laboratories, diagnostic devices, etc.) as possible. If these standardized clinical data can also be used to generate HIPAA- compliant billing transactions automatically, this will provide another incentive for adoption of clinical data standards. For the automated generation of bills from clinical data to become a reality, robust mappings from standard clinical terminologies to the HIPAA code sets must be created. To support the transition to ICD-10-CM in 2015, a map from SNOMED CT to ICD-10-CM is being created.
Materials Genome Initiative Committee, Work group, Advisory group, or Task Force FDA NIBIB The Office of Science and Technology Policy(OSTP) chartered this committee to create a new era of policy, resources, and infrastructure that support U.S. institutions in the effort to discover, manufacture, and deploy advanced materials twice as fast, at a fraction of the cost. Led by the National Institute of Standards and Technology(NIST), the National Science Foundation (NSF), and the Department of Defense (DoD) as co-leads it also includes the Food and Drug Administration (FDA), the National Aeronautics and Space Administration (NASA), and the Department of Energy (DoE).
Memorandum of Understanding (MOU) between the FDA Center for Devices and Radiological Health and NIH/NINDS Other FDA NINDS This MOU provides a mechanism for addressing cross-cutting issues related to the development of devices for neurological disorders, from bench science to clinical studies and the Food and Drug Administration (FDA) approval.
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS Other FDA NINDS This Memorandum of Understanding (MOU) provides a mechanism for addressing cross-cutting issues related to therapy development for neurological disorders, from bench science to clinical trials and the Food and Drug Administration (FDA) approval and licensure.
Microbiological Testing of Live Biotherapeutic Products Resource Development FDA NIAID The goal is to bring the purity and potency assays using the novel recombinant protein reagents to scale, as well as to optimize these methods and tools for tech transfer to facilitate the development and regulation of the Live Biotherapeutic Products (LBPs) for preventive and therapeutic use.
Micronutrient Forum Steering Committee Committee, Work group, Advisory group, or Task Force CDC NICHD The Micronutrient Forum serves as a global catalyst and convener for sharing expertise, insights and experience relevant to micronutrients in all aspects of health promotion and disease prevention, with special emphasis on the integration with relevant sectors. The primary objective of the MN Forum is to foster dialogue among the research, policy, clinical, program, and private sector communities to facilitate the translation of evidence for policy and program planning for micronutrients, and to inform research needs and priorities based on evidence gaps to support programs.
Mind Your Risks Public Education Campaign CDC, CMS NINDS The Mind Your Risks campaign is designed to create awareness and action about the fact that risk factors for stroke, particularly hypertension, may be linked to cognitive impairment and dementia.